TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +33.8% | +13.1% | +9.5% | +18.1% | -5.0% | +26.4% | -44.0% | +39.8% | +11.5% | +16.8% | -14.2% | +2.9% | -1.2% | -55.3% | +22.7% | -86.0% | +925.3% | +44.6% | -13.1% | +103.9% | +50.9% | +11.1% | -13.0% | -26.7% | +47.6% | -1.5% | |
| – | +0.7% | -15.4% | +5.4% | -6.3% | +11.2% | -8.0% | +0.3% | +10.0% | +272.6% | -2.8% | -7.1% | +40.7% | +64.6% | -12.7% | +21.0% | -24.4% | -13.1% | +6.2% | +36.0% | +135.6% | -4.1% | +4.2% | +13.9% | +9.6% | +4.6% | -5.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -27.7% | +4.6% | +21.0% | +7.9% | +45.0% | +29.3% | +15.2% | +39.9% | +16.8% | +2.8% | -0.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -320.7% | – | – | – | – | – | -87.6% | – | – | – | |
| – | – | – | +83.7% | -342.0% | – | – | – | – | – | – | -164.7% | – | -120.0% | – | – | -201.9% | – | -54.8% | +377.3% | +48.0% | +191.3% | -64.2% | -125.6% | – | – | – | |
| – | -23.9% | +39.3% | -10.8% | +61.8% | -0.9% | -40.2% | -9.2% | +11.9% | +21.0% | +120.4% | +42.8% | -42.8% | +58.0% | -30.1% | +38.5% | -21.9% | +32.0% | +14.5% | +4.6% | +62.3% | +8.6% | -21.3% | +240.6% | -24.1% | -21.0% | +9.2% | |
| – | +12.7% | – | +11.9% | -199.4% | -48.1% | – | +1,672.6% | -12.6% | -854.1% | -84.7% | -15.5% | +1,002.2% | -88.0% | +17.5% | – | -178.0% | +820.8% | -85.8% | +2,938.0% | – | +34.7% | -150.3% | +206.4% | -23.6% | -20.9% | +0.6% | |
| – | +30.7% | +32.6% | +12.1% | +11.8% | +23.1% | +14.1% | +15.5% | +30.8% | +10.3% | +0.8% | -1.0% | 0.0% | +0.1% | +0.0% | -0.3% | -0.1% | +0.1% | +0.1% | +0.7% | +97.7% | +0.3% | +0.1% | -1.5% | +2.8% | +5.3% | +3.1% | |
| – | – | – | – | – | – | -6.0% | +136,909.0% | -39.8% | +117.7% | -100.0% | +47.1% | -68.0% | +50.0% | +54.2% | +47,432.4% | +27.1% | +3.5% | -18.9% | -93.8% | +218.9% | -42.7% | +3,521.3% | -65.3% | -91.4% | +2,129.6% | -0.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +926.7% | -132.5% | – | -118.5% | +12.7% | -9.1% | -52.5% | – | -20,874.2% | – | |
| – | +50.2% | +25.6% | +12.0% | +0.6% | +24.5% | +20.8% | +253.8% | -17.0% | +62.5% | -65.2% | -1.0% | – | -138.7% | – | -411.9% | -58.5% | – | -212.5% | – | -134.1% | +8.3% | -1.7% | -33.7% | -50.0% | +112.0% | -33.9% | |
| – | +53.6% | +181.1% | -3.6% | -83.6% | +254.3% | +92.3% | -94.1% | -260.6% | – | – | -78.6% | -2,168.5% | – | +31.9% | -109.0% | – | – | – | – | -116.0% | – | -135.5% | – | – | – | – | |
| – | +50.3% | +9.3% | +13.3% | +11.7% | -5.9% | +41.2% | -47.3% | +44.3% | +10.4% | +2.6% | -31.1% | +30.9% | -17.0% | -68.1% | +5.1% | -180.4% | – | +67.1% | -22.1% | +132.6% | +71.3% | +21.0% | -63.3% | -31.4% | +187.6% | -7.5% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.